Actinium Pharmaceuticals names Sean Maenpaa senior vice president of business development
The appointment takes effect on October 12, 2026, and the new executive will lead partnering, licensing and strategic transactions across Actinium's targeted radiotherapy pipeline. He brings more than two decades of oncology business development experience, including senior roles at Bayer, Clovis Oncology, Telix Pharmaceuticals and BWXT Medical.
Primary source
Company press release (PR Newswire), October 16, 2026
Actinium Pharmaceuticals Appoints Radiopharmaceutical Industry Veteran Sean Maenpaa as Senior Vice President, Business Development
Machine-summarized from the source above; not independently reported. How we use automation